{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:58:22Z","timestamp":1790193502622,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":3302,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.ijid.2004.04.012","type":"journal-article","created":{"date-parts":[[2004,6,21]],"date-time":"2004-06-21T19:51:08Z","timestamp":1087847468000},"page":"223-226","source":"Crossref","is-referenced-by-count":146,"title":["Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound"],"prefix":"10.1016","volume":"8","author":[{"given":"Els","family":"Keyaerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leen","family":"Vijgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Hedenstierna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Van Ranst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2004.04.012_BIB1","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2004.04.012_BIB2","first-page":"1165","article-title":"Antiviral treatment of SARS: can we draw any conclusions?","volume":"169","author":"Zhaori","year":"2003","journal-title":"CMAJ"},{"key":"10.1016\/j.ijid.2004.04.012_BIB3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.ijid.2004.04.012_BIB4","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1128\/JVI.71.3.2202-2210.1997","article-title":"Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus","volume":"71","author":"Lane","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2004.04.012_BIB5","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0140-6736(03)13615-X","article-title":"Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus","volume":"361","author":"Cinatl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2004.04.012_BIB6","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0014-5793(02)02311-6","article-title":"Induction of inducible nitric oxide synthase expression by 18\u03b2-glycyrrherinic acid in macrophages","volume":"513","author":"Jeong","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ijid.2004.04.012_BIB7","first-page":"739","article-title":"Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates","volume":"218","author":"Ignarro","year":"1981","journal-title":"Pharmacol Exp Ther"},{"key":"10.1016\/j.ijid.2004.04.012_BIB8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0166-0934(88)90134-6","article-title":"Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds","volume":"20","author":"Pauwels","year":"1988","journal-title":"J Virol Methods"},{"key":"10.1016\/j.ijid.2004.04.012_BIB9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0022-1759(94)00277-4","article-title":"Microculture tetrazolium assays: a comparison between two new tetrazolium salts, XTT and MTS","volume":"179","author":"Goodwin","year":"1995","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.ijid.2004.04.012_BIB10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-2952(91)90406-U","article-title":"Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required","volume":"42","author":"Bates","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ijid.2004.04.012_BIB11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1139\/y91-135","article-title":"Interaction of glyceryl trinitrate and sodium nitroprusside with bovine pulmonary vein homogenate and 10,000 \u00d7 g supernatant: biotransformation and nitric oxide formation","volume":"69","author":"Marks","year":"1991","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.ijid.2004.04.012_BIB12","first-page":"916","article-title":"Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle","volume":"262","author":"Kowaluk","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ijid.2004.04.012_BIB13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1358\/dof.2000.025.07.858691","article-title":"Nitric oxide donor drugs","volume":"25","author":"Megson","year":"2000","journal-title":"Drugs of the Future"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971204000529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971204000529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T13:35:41Z","timestamp":1585834541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971204000529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S1201971204000529"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2004.04.012","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}